G

Global Antibiotic R&D Partnership (GARDP)

76 employees

GARDP aims to develop and deliver new treatments for bacterial infections where drug resistance is present or emerging

Basic info

Industry

research services

Sectors

Biotechnology
children’s antibiotics
sepsis and neonatal sepsis
sexually transmitted infections
global health
antibiotic access
pandemic preparedness
serious bacterial infections
public health
R&D partnerships
antibiotic drug development
Antibiotic resistance
gonorrhoea

Date founded

2016

FAQ